VOYA Investment Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.92M | Buy |
349,183
+17,003
| +5% | +$483K | 0.01% | 737 |
|
|
2025
Q1 | $9.81M | Sell |
332,180
-14,006
| -4% | -$413K | 0.01% | 743 |
|
|
2024
Q4 | $10.1M | Buy |
346,186
+3,714
| +1% | +$108K | 0.01% | 747 |
|
|
2024
Q3 | $15.7M | Buy |
342,472
+112,759
| +49% | +$5.18M | 0.02% | 623 |
|
|
2024
Q2 | $9.38M | Buy |
229,713
+205,192
| +837% | +$8.38M | 0.01% | 777 |
|
|
2024
Q1 | $626K | Sell |
24,521
-4,762
| -16% | -$122K | ﹤0.01% | 1900 |
|
|
2023
Q4 | $265K | Sell |
29,283
-23,504
| -45% | -$213K | ﹤0.01% | 2420 |
|
|
2023
Q3 | $337K | Buy |
52,787
+700
| +1% | +$4.47K | ﹤0.01% | 2248 |
|
|
2023
Q2 | $578K | Buy |
52,087
+3,534
| +7% | +$39.2K | ﹤0.01% | 2002 |
|
|
2023
Q1 | $745K | Buy |
48,553
+4,051
| +9% | +$62.2K | ﹤0.01% | 1819 |
|
|
2022
Q4 | $987K | Buy |
44,502
+24,866
| +127% | +$552K | ﹤0.01% | 1649 |
|
|
2022
Q3 | $321K | Buy |
19,636
+1,072
| +6% | +$17.5K | ﹤0.01% | 2308 |
|
|
2022
Q2 | $270K | Buy |
18,564
+3,776
| +26% | +$54.9K | ﹤0.01% | 2237 |
|
|
2022
Q1 | $273K | Hold |
14,788
| – | – | ﹤0.01% | 2216 |
|
|
2021
Q4 | $352K | Buy |
14,788
+680
| +5% | +$16.2K | ﹤0.01% | 2213 |
|
|
2021
Q3 | $347K | Buy |
14,108
+1,352
| +11% | +$33.3K | ﹤0.01% | 2259 |
|
|
2021
Q2 | $315K | Hold |
12,756
| – | – | ﹤0.01% | 2351 |
|
|
2021
Q1 | $278K | Buy |
+12,756
| New | +$278K | ﹤0.01% | 2350 |
|